Get special offers & coupons from participating businesses
Research popular baby products before you register.
From Prenatal yoga to baby music classes-find out what's happening.
Exchange thoughts and ideas with other new moms.
Phone: 1-877-LIFEBANKUSA (1-877-543-3226)
Expecting a baby? Whether this child is your first or an addition to your family, you want to do everything you can to provide for your newborn’s well-being now and in the future. That’s why you should think about cord blood banking – an investment that could impact the future of your baby and your immediate family.† Cord blood stem cells have been used to treat at least 80 different diseases1, 2 and are also being studied in an emerging field called regenerative medicine.* In the future, this exciting new science may revolutionize the treatment of many debilitating conditions,3,4 including muscular dystrophy,5 stroke6,7 and type 1 diabetes.8
You can collect and preserve potentially lifesaving stem cells through cord blood banking. You can bank even more stem cells by collecting them from 2 sources of stem cell-rich blood: the umbilical cord and the placenta.9 This service is called Placenta-Cord banking, and it’s onlyavailable from LifebankUSA. Having more stem cells available:
1-877-LIFEBANKUSA (1-877-543-3226) or visit us at www.lifebankusa.com
Cord blood and placenta-derived stem cells banked with LifebankUSA are indicated for hematopoietic reconstitution (the reformation of blood cellular components) for autologous use or use in first or second degree blood relatives. Any use of cord blood and placental stem cells other than for hematopoietic reconstitution is considered investigational, including regenerative medicine therapies.
The chance that a child will use his/her own stored stem cells during his/her lifetime for currently treated conditions is estimated at 1 in 400.13 These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client’s overall health. Talk with your health care provider.
*These uses are not consistent with current labeling, are investigational and may never become standard therapy.
†First or second degree blood relative.
1. The Leukemia & Lymphoma Society. Cord blood stem cell transplantation. No. 2. http://www.leukemia-lymphoma.org/attachments/National/br_1128624081.pdf. Accessed May 10, 2010. 2. St. Jude Children’s Research Hospital. Diseases treated by stem cell transplant. http://www.stjude.org/stjude/v/index.jsp. Accessed September 2, 2010. 3. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med. 2008;3(1):1-5. 4. US Department of Health and Human Services. 2020: a new vision – a future for regenerative medicine. http://www.hhs.gov/reference/newfuture.shtml. Accessed April 14, 2010. 5. Jazedje T, Secco M, Vieira NM, et al. Stem cells from umbilical cord blood do have myogenic potential, with and without differentiation induction in vitro. J Transl Med. 2009;7:6. 6. Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008;4(4):269-274. 7. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke. 2007;38(suppl 2):817-826. 8. Haller MJ, Viener H-L, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol. 2008;36(6):710-715. 9. Data on File. LifebankUSA, 2010. 10. Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol.2006;18:565-570. 11. Schoemans H, Theunissen K, Maertens J et al. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant. 2006:1-11. 12. Scaradavou A, on behalf of the National Cord Blood Program, New York Blood Center. Unrelated umbilical cord blood unit selection. Semin Hematol. 2010;47:13-21. 13.Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.